Maple Syrup Decreases TDP-43 Proteotoxicity in a Caenorhabditis elegans Model of Amyotrophic Lateral Sclerosis (ALS)

被引:18
|
作者
Aaron, Catherine [1 ]
Beaudry, Gabrielle [1 ]
Parker, J. Alex [1 ,2 ]
Therrien, Martine [1 ,3 ]
机构
[1] CRCHUM, 900 St Denis St, Montreal, PQ H2X 0A9, Canada
[2] Univ Montreal, Dept Neurosci, 2960 Chemin Tour, Montreal, PQ H3T 1J4, Canada
[3] Univ Montreal, Dept Pathol & Cell Biol, 2900 Edouard Montpetit Boul, Montreal, PQ H3T 1J4, Canada
基金
加拿大健康研究院;
关键词
C; elegans; ALS; maple syrup; TDP-43; GRAPE SEED EXTRACT; GALLIC ACID; ANTIOXIDANT ACTIVITY; IN-VITRO; TOXICITY; DEGENERATION; ALZHEIMERS; MUTATIONS; SURVIVAL; PATHWAY;
D O I
10.1021/acs.jafc.5b05432
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease causing death of the motor neurons. Proteotoxicity caused by TDP-43 protein is an important aspect of ALS pathogenesis, with TDP-43 being the main constituent of the aggregates found in patients. We have previously tested the effect of different sugars on the proteotoxicity caused by the expression of mutant TDP-43 in Caenorhabditis elegans. Here we tested maple syrup, a natural compound containing many active molecules including sugars and phenols, for neuroprotective activity. Maple syrup decreased several age-dependent phenotypes caused by the expression of TDP-43(A315T) in C. elegans motor neurons and requires the FOXO transcription factor DAF-16 to be effective.
引用
收藏
页码:3338 / 3344
页数:7
相关论文
共 50 条
  • [41] A Commentary on TDP-43 and DNA Damage Response in Amyotrophic Lateral Sclerosis
    Mitra, Joy
    Hegde, Muralidhar L.
    JOURNAL OF EXPERIMENTAL NEUROSCIENCE, 2019, 13
  • [42] Olfactory dysfunction related to TDP-43 pathology in amyotrophic lateral sclerosis
    Takeda, Takahiro
    Uchihara, Toshiki
    Kawamura, Shunji
    Ohashi, Takashi
    CLINICAL NEUROPATHOLOGY, 2014, 33 (01) : 65 - 67
  • [43] TDP-43 aggregation as a possible therapeutic target for Amyotrophic Lateral Sclerosis
    Cragnaz, Lucia
    Romano, Valentina
    Baralle, Francisco Ernesto
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2016, 50 (04): : 649 - 655
  • [44] TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis
    Beyer, Leon
    Guenther, Rene
    Koch, Jan Christoph
    Klebe, Stephan
    Hagenacker, Tim
    Lingor, Paul
    Biesalski, Anne-Sophie
    Hermann, Andreas
    Nabers, Andreas
    Gold, Ralf
    Toenges, Lars
    Gerwert, Klaus
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (01): : 271 - 277
  • [45] PHOSPHORYLATED TDP-43 ACCUMULATES IN THE SKIN OF PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS
    Nolano, Maria
    Provitera, Vincenzo
    Caporaso, Giuseppe
    Stancanelli, Annamaria
    Borreca, Ilaria
    Manganelli, Fiore
    Santoro, Lucio
    Dubbioso, Raffaele
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S36 - S36
  • [46] TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis
    Sarah Lépine
    Maria José Castellanos-Montiel
    Thomas Martin Durcan
    Translational Neurodegeneration, 11
  • [47] Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
    Prasad, Archana
    Bharathi, Vidhya
    Sivalingam, Vishwanath
    Girdhar, Amandeep
    Patel, Basant K.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [48] TDP-43 Proteinopathy: Aggregation and Propagation in the Pathogenesis of Amyotrophic Lateral Sclerosis
    Meriggioli, Matthew N.
    Kordower, Jeffrey H.
    MOVEMENT DISORDERS, 2016, 31 (08) : 1139 - 1139
  • [49] Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases
    Felix Geser
    Maria Martinez-Lage
    Linda K. Kwong
    Virginia M.-Y. Lee
    John Q. Trojanowski
    Journal of Neurology, 2009, 256 : 1205 - 1214
  • [50] Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis
    Axel Freischmidt
    Kathrin Müller
    Albert C Ludolph
    Jochen H Weishaupt
    Acta Neuropathologica Communications, 1